Clinical trial · Interventional
Clinical Utility Study for Exo-PDAC
Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Biological Dynamic's Exo-PDAC Test: A CPV® Randomized Controlled Trial
NCT05702385CI-TRIAL-00072061withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): The study sponsor did not wish to proceed with the study
Summary
Brief summary (as posted)
This is a national-level research study of oncologists, interventional gastroenterologists, and primary care providers. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreas Cancer | Pancreatic Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Educational Materials for a new diagnostic test | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- NO_INTERVENTION
- label
- Standard Practice
- description
- The control group treats their simulated patients using standard practice and has no introduction to the new diagnostic test.
- type
- EXPERIMENTAL
- label
- Intervention Group 1 - Test Results Given
- description
- Intervention Group 1 will receive information regarding the test and will be given the test results, whether selected or not, in Round 2 of CPV administration.
- interventionNames
- Other: Educational Materials for a new diagnostic test
- type
- EXPERIMENTAL
- label
- Intervention Group 2 - Test Results Optional
- description
- Intervention Group 2 will receive information regarding the test and will be given the test results if selected in Round 2 of CPV administration.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Board-certified for at least two years * Averaging at least 20 hours per week of clinical and patient care duties over the last six months * Routinely evaluate patients at risk for pancreatic cancer in their practice * Practicing in the U.S. * English speaking * Access to the internet * Informed, signed, and voluntarily consented to be in the study Exclusion Criteria: * Non-English speaking * Unable to access the internet * Not practicing in the U.S. * Not averaging at least 20 hours per week of clinical or patient care duties over the last six months * Previous exposure to the test * Do not voluntarily consent to be in the study
References
Publications (0)
Data not yet available
No reference posted for this study.